IDEXX Laboratories, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportAug 4 →InsidersNo open-market buys. 5 insiders sold $36.5M, 0 of 35 sales on a 10b5-1 plan.→HoldersBlackRock 10.4%Vanguard 6.5%Vanguard Portfolio 4.9%→PeersClosest companies: ZTS, A, MLAB→
From the filings
Figures
- Revenue
- $4.55Blast 12 months
- Net income
- $1.14Blast 12 months
- Operating cash flow
- $1.21Blast 12 months
- Cash and equivalents
- $196.9Mat the last balance sheet
- Total debt
- $449.9Mat the last balance sheet
- Shares outstanding
- 78.9M shareson issue